Loading organizations...
The Alzheimer's Drug Discovery Foundation (ADDF) operates as a venture philanthropy organization, accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. It employs a strategic approach of funding high-risk, novel research across academic and biotechnology sectors, translating insights from the biology of aging into therapeutic solutions by bridging critical early-stage development gaps.
The ADDF was established in 1998 by brothers Leonard A. Lauder and Ronald S. Lauder. Their founding insight was the pressing need for a singular organization exclusively focused on addressing the early-stage funding deficit in Alzheimer's drug discovery, thereby enabling promising scientific endeavors to advance.
The foundation primarily supports researchers and biotechnology innovators, whose work ultimately aims to benefit the global population affected by Alzheimer's disease. The ADDF’s long-term vision is to conquer this devastating illness by aggressively advancing the most promising research worldwide, striving to halt its progression.
Key people at Alzheimer's Drug Discovery Foundation.
Alzheimer's Drug Discovery Foundation was founded in 1998 by Leonard Lauder (Co-Chairman & Co-Founder) and Ronald S. Lauder (Co-Chairman and Co-Founder).
Key people at Alzheimer's Drug Discovery Foundation.
Alzheimer's Drug Discovery Foundation was founded in 1998 by Leonard Lauder (Co-Chairman & Co-Founder) and Ronald S. Lauder (Co-Chairman and Co-Founder).
